{"id":"https://openalex.org/W2980913702","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.633","title":"Identification of patients at high risk of recurrent disease development by detection of HER2-positive disseminated tumor cells in bone marrow of patients with HER2-negative tumors.","display_name":"Identification of patients at high risk of recurrent disease development by detection of HER2-positive disseminated tumor cells in bone marrow of patients with HER2-negative tumors.","publication_year":2013,"publication_date":"2013-05-20","ids":{"openalex":"https://openalex.org/W2980913702","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.633","mag":"2980913702"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2013.31.15_suppl.633","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.633","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.15_suppl.633","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054757298","display_name":"Rebecca Aft","orcid":"https://orcid.org/0000-0001-8569-7131","observed_orcids":["https://orcid.org/0000-0001-8569-7131"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rebecca Aft","raw_affiliation_strings":["Washington University in St. Louis, St. Louis, MO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Washington University in St. Louis, St. Louis, MO","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004954876","display_name":"Chidananda Mudalagiriyappa","orcid":"https://orcid.org/0000-0002-6942-6793","observed_orcids":["https://orcid.org/0000-0002-6942-6793"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chidananda Mudalagiriyappa","raw_affiliation_strings":["Washington University in St. Louis, St. Louis, MO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Washington University in St. Louis, St. Louis, MO","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102019130","display_name":"Sreeraj G. Pillai","orcid":"https://orcid.org/0000-0002-0285-0813","observed_orcids":["https://orcid.org/0000-0002-0285-0813"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sreeraj Pillai","raw_affiliation_strings":["Washington University in St. Louis, St. Louis, MO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Washington University in St. Louis, St. Louis, MO","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048989612","display_name":"Kathryn M. Trinkaus","orcid":"https://orcid.org/0000-0002-8826-5040","observed_orcids":["https://orcid.org/0000-0002-8826-5040"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kathryn Trinkaus","raw_affiliation_strings":["Washington University in St. Louis, St. Louis, MO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Washington University in St. Louis, St. Louis, MO","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008456176","display_name":"Timothy P. Fleming","orcid":"https://orcid.org/0000-0002-8661-1210","observed_orcids":["https://orcid.org/0000-0002-8661-1210"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Timothy Fleming","raw_affiliation_strings":["Washington University in St. Louis, St. Louis, MO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Washington University in St. Louis, St. Louis, MO","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5007830810","display_name":"Mark A. Watson","orcid":"https://orcid.org/0000-0002-3935-9980","observed_orcids":["https://orcid.org/0000-0002-3935-9980"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark Watson","raw_affiliation_strings":["Washington University School of Medicine in St. Louis, St. Louis, MO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Washington University School of Medicine in St. Louis, St. Louis, MO","institution_ids":["https://openalex.org/I204465549"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I204465549"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"31","issue":"15_suppl","first_page":"633","last_page":"633"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.004000000189989805,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/her2-negative-breast-cancer","display_name":"HER2-negative breast cancer","score":0.9089999794960022},{"id":"https://openalex.org/keywords/disseminated-tumor-cells","display_name":"disseminated tumor cells","score":0.9430000185966492},{"id":"https://openalex.org/keywords/bone-marrow","display_name":"bone marrow","score":0.9810000061988831},{"id":"https://openalex.org/keywords/recurrence","display_name":"recurrence","score":0.7450000047683716},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.9319999814033508},{"id":"https://openalex.org/keywords/risk-stratification","display_name":"risk stratification","score":0.6800000071525574},{"id":"https://openalex.org/keywords/early-breast-cancer","display_name":"early breast cancer","score":0.7429999709129333},{"id":"https://openalex.org/keywords/disease-free-survival","display_name":"disease-free survival","score":0.6779999732971191}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9190040826797485},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.7349399924278259},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6294130086898804},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.5974872708320618},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5885217189788818},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5792802572250366},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.5366648435592651},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.45391562581062317},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.4351118803024292},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4247652292251587},{"id":"https://openalex.org/C2777329042","wikidata":"https://www.wikidata.org/wiki/Q420323","display_name":"Lapatinib","level":5,"score":0.42385411262512207},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.3741922378540039},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.176398366689682},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2013.31.15_suppl.633","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.633","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.15_suppl.633","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2254270362","https://openalex.org/W2065837788","https://openalex.org/W2080670966","https://openalex.org/W2024032315","https://openalex.org/W2017981743","https://openalex.org/W3000432768","https://openalex.org/W2289174232","https://openalex.org/W2025539179","https://openalex.org/W2190500722","https://openalex.org/W2688374617"],"abstract_inverted_index":{"633":[0],"Background:":[1],"A":[2],"subpopulation":[3],"of":[4,30,66,88,130,162,175,178,185,187,209,248,254,262,274,279],"patients":[5,35,117,132,155,165,180,189,212,226,267,275],"with":[6,46,172,190,198,213,221,227,268],"HER2-negative":[7,191,199,214,269],"tumors":[8,20,168,192,251,270],"benefit":[9,283],"from":[10,53,115,284],"HER2":[11,13],"therapy.":[12],"expression":[14,65,77,247],"can":[15],"be":[16],"discordant":[17,246],"between":[18,62,143],"primary":[19],"and":[21,43,98,145,169,252],"metastases.":[22],"We":[23,243],"have":[24,205,244],"examined":[25],"the":[26,44,131,146,163,188],"bone":[27],"marrow":[28],"(BM)":[29],"early":[31],"stage":[32,55,255],"breast":[33,57,257],"cancer":[34,58,258],"for":[36],"HER2-expression":[37],"by":[38,70,94],"disseminated":[39],"tumor":[40],"cells":[41],"(DTCs)":[42],"association":[45],"disease":[47,238],"recurrence.":[48],"Methods:":[49],"BM":[50,114,201,216,229,253],"was":[51,68,78,92,106,118,122,140],"collected":[52],"clinical":[54],"II-III":[56,256],"prior":[59],"to":[60,108,204],"treatment":[61],"2007-2011.":[63],"Gene":[64],"ERBB2":[67,137,157,263],"determined":[69],"multiplex":[71],"PCR":[72,97],"(Fluidigm":[73],"Biomark":[74],"[FB]).":[75],"Positive":[76],"defined":[79],"as":[80],"at":[81,276],"least":[82],"1.4":[83],"fold":[84],"above":[85],"a":[86,206,236,272],"pool":[87],"normal":[89],"BM.":[90,160],"Expression":[91],"confirmed":[93],"single":[95],"gene":[96],"Nanostring":[99],"nCounter":[100],"(NC)":[101],"assays.":[102],"Cox":[103],"proportional":[104],"model":[105],"used":[107],"estimate":[109],"hazard":[110,208],"ratios":[111],"(HR).":[112],"Results:":[113],"74":[116],"analyzed.":[119],"Median":[120],"follow-up":[121],"3.4":[123],"years":[124],"(range":[125],"8":[126],"months-84":[127],"months).":[128],"24%":[129],"developed":[133],"metastatic":[134],"disease.":[135],"For":[136],"detection,":[138],"there":[139],"excellent":[141],"correlation":[142],"NC":[144],"FB":[147],"assays":[148],"(kappa=0.87,":[149],"95%":[150],"CI":[151],"[0.62,":[152],"1.00]).":[153],"Nine":[154],"expressed":[156],"in":[158,250,266],"their":[159],"Five":[161],"9":[164],"had":[166,235],"Her2-positive":[167],"were":[170,202],"treated":[171,220],"trastuzumab.":[173],"One":[174],"5":[176],"(20%)":[177],"these":[179],"relapsed":[181],"whereas":[182],"75%":[183],"(3":[184],"4)":[186],"but":[193],"ERBB2-positive":[194,218,228],"DTCs":[195,219,265],"relapsed.":[196],"Patients":[197],"tumors/ERBB2-positive":[200],"found":[203,245],"greater":[207],"recurrence":[210,280],"than":[211],"tumors/ERBB2-negative":[215],"or":[217],"trastuzumab":[222,234],"(p=.0069;":[223],"Table).":[224],"Those":[225],"who":[230,281],"did":[231],"not":[232],"receive":[233],"decreased":[237],"free":[239],"survival":[240],"(p=.016).":[241],"Conclusions:":[242],"HER2/ERBB2":[249],"patients.":[259],"The":[260],"presence":[261],"expressing":[264],"identifies":[271],"subset":[273],"increased":[277],"risk":[278],"may":[282],"targeted":[285],"HER2-therapy.":[286],"[Table:":[287],"see":[288],"text]":[289],".":[290]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2019-10-25T00:00:00"}